Law360, New York (December 15, 2011, 2:53 PM ET) -- Johnson & Johnson unit Janssen Pharmaceuticals Inc. slapped Sandoz Inc. with a patent infringement lawsuit Tuesday in New Jersey federal court in an effort to keep the company from marketing its own version of the injectable antibiotic Doribax.
Janssen lodged the suit after Sandoz filed an abbreviated new drug application with the U.S. Food and Drug Administration seeking permission to manufacture a generic version of doripenem for injection, which Janssen sells as Doribax, according to the pharmaceutical company's complaint.
Doribax is used to treat intra-abdominal and...
J&J Unit Aims To Thwart Sandoz's Generic Doribax
To view the full article, take a free trial now.
